193 related articles for article (PubMed ID: 22363823)
1. Evaluation of the human IgG antibody response to Aedes albopictus saliva as a new specific biomarker of exposure to vector bites.
Doucoure S; Mouchet F; Cornelie S; DeHecq JS; Rutee AH; Roca Y; Walter A; Hervé JP; Misse D; Favier F; Gasque P; Remoue F
PLoS Negl Trop Dis; 2012; 6(2):e1487. PubMed ID: 22363823
[TBL] [Abstract][Full Text] [Related]
2. Specific human antibody responses to Aedes aegypti and Aedes polynesiensis saliva: A new epidemiological tool to assess human exposure to disease vectors in the Pacific.
Mathieu-Daudé F; Claverie A; Plichart C; Boulanger D; Mphande FA; Bossin HC
PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006660. PubMed ID: 30040826
[TBL] [Abstract][Full Text] [Related]
3. Analysis in a murine model points to IgG responses against the 34k2 salivary proteins from Aedes albopictus and Aedes aegypti as novel promising candidate markers of host exposure to Aedes mosquitoes.
Buezo Montero S; Gabrieli P; Severini F; Picci L; Di Luca M; Forneris F; Facchinelli L; Ponzi M; Lombardo F; Arcà B
PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007806. PubMed ID: 31618201
[TBL] [Abstract][Full Text] [Related]
4. Human IgG responses to the Aedes albopictus 34k2 salivary protein: analyses in Réunion Island and Bolivia confirm its suitability as marker of host exposure to the tiger mosquito.
Buezo Montero S; Gabrieli P; Poinsignon A; Zamble BZH; Lombardo F; Remoue F; Arcà B
Parasit Vectors; 2022 Jul; 15(1):260. PubMed ID: 35858924
[TBL] [Abstract][Full Text] [Related]
5. First attempt to validate human IgG antibody response to Nterm-34kDa salivary peptide as biomarker for evaluating exposure to Aedes aegypti bites.
Elanga Ndille E; Doucoure S; Damien G; Mouchet F; Drame PM; Cornelie S; Noukpo H; Yamadjako S; Djenontin A; Moiroux N; Misse D; Akogbeto M; Corbel V; Henry MC; Chandre F; Baldet T; Remoue F
PLoS Negl Trop Dis; 2012; 6(11):e1905. PubMed ID: 23166852
[TBL] [Abstract][Full Text] [Related]
6. Human IgG Antibody Response to Aedes Nterm-34kDa Salivary Peptide, an Epidemiological Tool to Assess Vector Control in Chikungunya and Dengue Transmission Area.
Elanga Ndille E; Doucoure S; Poinsignon A; Mouchet F; Cornelie S; D'Ortenzio E; DeHecq JS; Remoue F
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005109. PubMed ID: 27906987
[TBL] [Abstract][Full Text] [Related]
7. IgG Antibody Responses to the
Buezo Montero S; Gabrieli P; Montarsi F; Borean A; Capelli S; De Silvestro G; Forneris F; Pombi M; Breda A; Capelli G; Arcà B
Front Cell Infect Microbiol; 2020; 10():377. PubMed ID: 32850479
[TBL] [Abstract][Full Text] [Related]
8. Risk factors of exposure to Aedes albopictus bites in mainland France using an immunological biomarker.
Poinsignon A; Boulanger D; Binetruy F; Elguero E; Darriet F; Gallian P; De Lamballerie X; Charrel RN; Remoue F
Epidemiol Infect; 2019 Jan; 147():e238. PubMed ID: 31364567
[TBL] [Abstract][Full Text] [Related]
9. Human antibody response to Aedes albopictus salivary proteins: a potential biomarker to evaluate the efficacy of vector control in an area of Chikungunya and Dengue Virus transmission.
Doucoure S; Mouchet F; Cornelie S; Drame PM; D'Ortenzio E; DeHecq JS; Remoue F
Biomed Res Int; 2014; 2014():746509. PubMed ID: 24822216
[TBL] [Abstract][Full Text] [Related]
10. Relationship between exposure to vector bites and antibody responses to mosquito salivary gland extracts.
Fontaine A; Pascual A; Orlandi-Pradines E; Diouf I; Remoué F; Pagès F; Fusaï T; Rogier C; Almeras L
PLoS One; 2011; 6(12):e29107. PubMed ID: 22195000
[TBL] [Abstract][Full Text] [Related]
11. Aedes aegypti anti-salivary gland antibody concentration and dengue virus exposure history in healthy individuals living in an endemic area in Colombia.
Londoño-Rentería B; Cárdenas JC; Giovanni JE; Cárdenas L; Villamizar P; Rolón J; Chisenhall DM; Christofferson RC; Carvajal DJ; Pérez OG; Wesson DM; Mores CN
Biomedica; 2015; 35(4):572-81. PubMed ID: 26844447
[TBL] [Abstract][Full Text] [Related]
12. Human IgG response to a salivary peptide, gSG6-P1, as a new immuno-epidemiological tool for evaluating low-level exposure to Anopheles bites.
Poinsignon A; Cornelie S; Ba F; Boulanger D; Sow C; Rossignol M; Sokhna C; Cisse B; Simondon F; Remoue F
Malar J; 2009 Aug; 8():198. PubMed ID: 19674487
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to
Chea S; Willen L; Nhek S; Ly P; Tang K; Oristian J; Salas-Carrillo R; Ponce A; Leon PCV; Kong D; Ly S; Sath R; Lon C; Leang R; Huy R; Yek C; Valenzuela JG; Calvo E; Manning JE; Oliveira F
Front Immunol; 2024; 15():1368066. PubMed ID: 38751433
[TBL] [Abstract][Full Text] [Related]
14. Serological biomarker for assessing human exposure to Aedes mosquito bites during a randomized vector control intervention trial in northeastern Thailand.
Fustec B; Phanitchat T; Aromseree S; Pientong C; Thaewnongiew K; Ekalaksananan T; Cerqueira D; Poinsignon A; Elguero E; Bangs MJ; Alexander N; Overgaard HJ; Corbel V
PLoS Negl Trop Dis; 2021 May; 15(5):e0009440. PubMed ID: 34043621
[TBL] [Abstract][Full Text] [Related]
15. IgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal.
Drame PM; Machault V; Diallo A; Cornélie S; Poinsignon A; Lalou R; Sembène M; Dos Santos S; Rogier C; Pagès F; Le Hesran JY; Remoué F
Malar J; 2012 Mar; 11():72. PubMed ID: 22424570
[TBL] [Abstract][Full Text] [Related]
16. Human IgG antibody response to Aedes aegypti Nterm-34 kDa salivary peptide as an indicator to identify areas at high risk for dengue transmission: a retrospective study in urban settings of Vientiane city, Lao PDR.
Ndille EE; Dubot-Pérès A; Doucoure S; Mouchet F; Cornelie S; Sidavong B; Fournet F; Remoue F
Trop Med Int Health; 2014 May; 19(5):576-80. PubMed ID: 24641205
[TBL] [Abstract][Full Text] [Related]
17. First screening of Aedes albopictus immunogenic salivary proteins.
Doucoure S; Cornelie S; Patramool S; Mouchet F; Demettre E; Seveno M; Dehecq JS; Rutee H; Herve JP; Favier F; Missé D; Gasque P; Remoue F
Insect Mol Biol; 2013 Aug; 22(4):411-23. PubMed ID: 23714164
[TBL] [Abstract][Full Text] [Related]
18. Spatial Assessment of Contact Between Humans and Anopheles and Aedes Mosquitoes in a Medium-Sized African Urban Setting, Using Salivary Antibody-Based Biomarkers.
Sagna AB; Kassié D; Couvray A; Adja AM; Hermann E; Riveau G; Salem G; Fournet F; Remoue F
J Infect Dis; 2019 Aug; 220(7):1199-1208. PubMed ID: 31152664
[TBL] [Abstract][Full Text] [Related]
19. Human antibody response to Aedes aegypti saliva in an urban population in Bolivia: a new biomarker of exposure to Dengue vector bites.
Doucoure S; Mouchet F; Cournil A; Le Goff G; Cornelie S; Roca Y; Giraldez MG; Simon ZB; Loayza R; Misse D; Flores JV; Walter A; Rogier C; Herve JP; Remoue F
Am J Trop Med Hyg; 2012 Sep; 87(3):504-10. PubMed ID: 22848099
[TBL] [Abstract][Full Text] [Related]
20. Human IgG responses to Aedes mosquito salivary peptide Nterm-34kDa and its comparison to Anopheles salivary antigen (gSG6-P1) IgG responses measured among individuals living in Lower Moshi, Tanzania.
Kassam NA; Laswai D; Kulaya N; Kaaya RD; Kajeguka DC; Schmiegelow C; Wang CW; Alifrangis M; Kavishe RA
PLoS One; 2022; 17(10):e0276437. PubMed ID: 36301860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
